LYVE1 anticorps (AA 24-228)
Aperçu rapide pour LYVE1 anticorps (AA 24-228) (ABIN2745545)
Antigène
Voir toutes LYVE1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 24-228
-
Fonction
- anti-LYVE-1, pAb
-
Specificité
- Recognizes mouse and rat LYVE-1.
-
Attributs du produit
- Polyclonal Antibody. Recognizes mouse and rat LYVE-1. Source: Rabbit. Applications: ELISA, FACS, IHC, WB. Lyophilized. LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. Like CD44, the LYVE-1 Molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 Molecule co-localizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.
-
Purification
- Antigen affinity purified.
-
Pureté
- Antigen affinity purified.
-
Immunogène
- Recombinant mouse soluble LYVE-1 (aa24-228).
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Centrifuge vial prior to opening. Reconstitute with sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- Lyophilized.
-
Conseil sur la manipulation
- After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
+4°C
-20°C
Stable for at least 6 months after receipt when stored at -20°C.
-
Date de péremption
- 6 months
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Autre désignation
- Lyve1
-
Sujet
-
Alternate Names/Synonyms: Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, CRSBP-1
Product Description: LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. Like CD44, the LYVE-1 Molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 Molecule co-localizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.
-
UniProt
- Q8BHC0
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-